End-Organ Protection in Patients with Hypertension

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008

(2010) Brent M. Egan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Therapeutic inhibition of the renin angiotensin aldosterone system

(2009) David W Laight   EXPERT OPINION ON THERAPEUTIC PATENTS

Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial

(2009) Jan Menne et al.   JOURNAL OF HYPERTENSION

Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study

(2009) Sebastiano Sciarretta et al.   JOURNAL OF HYPERTENSION

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

(2008) David H G Smith   DRUGS

Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy

(2008) Ingrid Os et al.   HYPERTENSION

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE